The median wait time between referral and appointment was 34 days, and 18 percent of patients waited more than 90 days, the study found.

Although Medicare enrollees typically don't pay a premium for Part A, which covers hospital care, there's a cost for being admitted to the hospital. In 2025, you'll face a $1,676 inpatient deductible, up from $1,632 in 2024.

If you missed Medicare's open enrollment period, which runs from October 15 to December 7 each year, you may be wondering if there's still a way to enroll or adjust your coverage w

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price negotiations, federal health officials announced Friday. The negotiations for the 15 additional drugs, which will be handled by the incoming administration, assure major savings for Americans.

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.

Medicare premiums and deductibles have increased for all retirees. There's now a $2,000 cap on annual out-of-pocket prescription drug costs. Some Medicare services, like telehealth, have gotten more restrictive in 2025.

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations for 10 drugs whose lower prices take effect in 2026. T

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk's blockbuster weight-loss drug Wegovy.Here's

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden administration announced Friday.

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk's blockbuster weight-loss drug Wegovy. Here's